Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Helix Biopharma Corp. (HBPCF) had Return on Equity of -4.52% for the most recently reported fiscal quarter, ending 2026-01-31.
| Income Statement Financials | |
-- |
|
$-0.50M |
|
-- |
|
-- |
|
$0.49M |
|
$-0.49M |
|
$-0.01M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.50M |
|
$-0.49M |
|
$-0.49M |
|
76.38M |
|
76.38M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.10M |
|
$0.00M |
|
$13.26M |
|
$13.36M |
|
$2.28M |
|
-- |
|
-- |
|
$2.28M |
|
$11.08M |
|
$-2.18M |
|
$11.08M |
|
76.38M |
|
| Cash Flow Statement Financials | |
$-1.21M |
|
-- |
|
$1.19M |
|
$0.05M |
|
$0.02M |
|
$-0.02M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-4.52% |
22.92% |
|
-3.75% |
|
-4.52% |
|
$0.14 |
|
$-0.02 |
|
$-0.02 |
|